Fingerprint
Dive into the research topics of 'Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program (American Journal of Clinical Dermatology, (2021), 22, 5, (693-707), 10.1007/s40257-021-00618-3)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically